ARCHIVES

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Varmus: NCI Faces “Budgetary Disaster;” Flat Funds, Cuts Loom For Most Programs

January 14, 2011

Panel Urges Research On DCIS To Identify Women At High Risk For Invasive Cancer

September 25, 2009

Clinton Names Broadnax HHS Deputy, Others to Sub-Cabinet Posts

March 5, 1993

In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application

June 20, 1980

In Congress: Senate Passes Bill For DOD Medical Research Funding

August 14, 1998

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991